Osteoporosis and BHRT
Osteoporosis is characterized by low bone mineral density, compromised bone strength, and increased fracture risk. It is one of the most common bone diseases in humans. Currently, the National Osteoporosis Foundation estimates that more than 10 million Americans have osteoporosis and an additional 33.6 million have osteopenia. Together, osteoporosis and osteopenia affect the majority of postmenopausal women in the United States, and 1 in 2 white women can expect to experience an osteoporotic fracture at some time in her life.
Estrogen and testosterone therapy is approved for the prevention of osteoporosis. Estrogen therapy’s protective effect against bone loss was one of the findings of the Women’s Health Initiative (WHI) first reported back in 2002. For postmenopausal women who experience bone loss despite a healthy lifestyle, BHRT might offer a viable alternative to other medications for the prevention of osteoporosis.
Bioidentical hormones are derived from naturally-occurring sources and are designed to replicate the molecular structure of hormones produced naturally in your body. Before starting on BHRT, we will perform a Hormone Panel to determine your individual hormone needs.
When you’re ready to get started, give our office a call at 201-255-2525 to schedule your consultation. May is National Osteoporosis Awareness & Prevention Month. There’s never been a better time to be proactive about your bone health.